Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases

NAUnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2022

Conditions

Breast CancerBrain Metastases

Interventions

DEVICE

ExAblate BBBD

Using ExAblate Model 4000 Type-2 to temporarily disrupt the blood brain barrier in patients with Her-2 positive breast cancer and brain metastases

Trial Locations (1)

RECRUITING

Sunnybrook Health Sciences Centre, Toronto